New issue
Percutaneous recanalisation of CTO, FAST-TAVI trial, substudy from DANAMI-3-PRIMULTI... discover the latest issue
Computation of OFR by OCT on a LAD with physiologically non-significant stenosis.
June 24, 2019
1. Ludwig Boltzmann Cluster for Cardiovascular Research at the Center for Biomedical Research, Medical University of Vienna, Vienna, Austria, AUSTRIA
2. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
3. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
4. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
5. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
2. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
3. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
4. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
5. Ludwig Boltzmann Cluster for Cardiovascular Research at the Centre for Biomedical Research, Medical University of Vienna, Vienna, Austria
Disclaimer:
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers.
To read the full content of this article, please log in to download the PDF.
Introduction: Alternative approaches for mitral valve repair are being constantly developed. Even though the safety of these devices has been extensively assessed in healthy animals before approval for first-in-man studies, often the efficacy of these new devices has been hardly challenged in vivoin the setting of MR. Therefore, reliable and reproducible preclinical animal models of MR are crucial to allow not only the safety assessment but also the efficacy evaluation of these novel approaches.
Sign in to read and download the full article
Forgot your password?No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
